JAMA:局部枸橼酸盐vs全身肝素抗凝对持续肾脏替代治疗过滤器寿命及患者死亡率的影响

2020-10-28 MedSci原创 MedSci原创

在接受持续肾脏替代治疗的急性肾损伤危重患者中,与全身肝素抗凝相比,局部枸橼酸盐抗凝可显著延长过滤器寿命,但抗凝治疗对患者死亡率的影响差异不显著

目前的指南建议,在危重患者连续肾脏替代治疗中使用局部枸橼酸盐抗凝,即在体外透析回路过滤前向血液中添加柠檬酸盐溶液,但这一结论主要依据少量临床和荟萃分析的结果。近日研究人员比较了局部枸橼酸盐抗凝与全身肝素抗凝,对过滤器使用寿命和患者死亡率的影响。
 
本次研究在德国26个医疗中心开展。在596名需接受肾脏替代治疗的严重急性肾损伤或临床其他适应症的危重病人参与,患者随机接受局部枸橼酸盐抗凝(n=300),其目标电离钙水平为1.0至1.40 mg/dL,或全身肝素抗凝(n=296),其目标激活部分凝血活酶时间为45至60秒。研究的主要终点为过滤器寿命和90天死亡率。次要终点包括出血并发症和新感染
 
638名患者中,596名(93.4%)完成了试验(平均年龄67.5岁;183名女性)。局部枸橼酸盐组和全身肝素组相比较,平均过滤器寿命分别为47小时和26小时(差异:15小时)。局部枸橼酸盐组300例患者中150例90天内死亡,而在全身肝素抗凝组296例患者中156例死亡( 51.2% vs 53.6%;未经调整的差异为-2.4%;未调整的危险比为0.91;调整后的差异为-6.1%;调整后差异危险比:0.79)。在38个预先指定的次要终点中,34个没有显著差异。与全身肝素组相比,局部枸橼酸盐组出血并发症明显减少(5.1% vs 16.9%),新感染明显增多(68.0% vs 55.4%)。
 
研究认为,在接受持续肾脏替代治疗的急性肾损伤危重患者中,与全身肝素抗凝相比,局部枸橼酸盐抗凝可显著延长过滤器寿命,但抗凝治疗对患者死亡率的影响差异不显著。
 
原始出处
 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1692871, encodeId=884716928e12c, content=<a href='/topic/show?id=e6d86032ee8' target=_blank style='color:#2F92EE;'>#替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60327, encryptionId=e6d86032ee8, topicName=替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b79d29305168, createdName=wfang555, createdTime=Mon Apr 05 12:01:01 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983692, encodeId=ca51198369295, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Sep 06 20:01:01 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035053, encodeId=915220350537e, content=<a href='/topic/show?id=f02e56353ac' target=_blank style='color:#2F92EE;'>#持续肾脏替代治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56353, encryptionId=f02e56353ac, topicName=持续肾脏替代治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f9e287, createdName=hxzhang, createdTime=Mon Feb 08 05:01:01 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394753, encodeId=eb4a1394e534e, content=<a href='/topic/show?id=e31982e0603' target=_blank style='color:#2F92EE;'>#肾脏替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82706, encryptionId=e31982e0603, topicName=肾脏替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406003, encodeId=755b1406003d3, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036323, encodeId=3fde103632393, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Oct 28 21:01:01 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1692871, encodeId=884716928e12c, content=<a href='/topic/show?id=e6d86032ee8' target=_blank style='color:#2F92EE;'>#替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60327, encryptionId=e6d86032ee8, topicName=替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b79d29305168, createdName=wfang555, createdTime=Mon Apr 05 12:01:01 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983692, encodeId=ca51198369295, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Sep 06 20:01:01 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035053, encodeId=915220350537e, content=<a href='/topic/show?id=f02e56353ac' target=_blank style='color:#2F92EE;'>#持续肾脏替代治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56353, encryptionId=f02e56353ac, topicName=持续肾脏替代治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f9e287, createdName=hxzhang, createdTime=Mon Feb 08 05:01:01 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394753, encodeId=eb4a1394e534e, content=<a href='/topic/show?id=e31982e0603' target=_blank style='color:#2F92EE;'>#肾脏替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82706, encryptionId=e31982e0603, topicName=肾脏替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406003, encodeId=755b1406003d3, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036323, encodeId=3fde103632393, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Oct 28 21:01:01 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1692871, encodeId=884716928e12c, content=<a href='/topic/show?id=e6d86032ee8' target=_blank style='color:#2F92EE;'>#替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60327, encryptionId=e6d86032ee8, topicName=替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b79d29305168, createdName=wfang555, createdTime=Mon Apr 05 12:01:01 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983692, encodeId=ca51198369295, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Sep 06 20:01:01 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035053, encodeId=915220350537e, content=<a href='/topic/show?id=f02e56353ac' target=_blank style='color:#2F92EE;'>#持续肾脏替代治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56353, encryptionId=f02e56353ac, topicName=持续肾脏替代治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f9e287, createdName=hxzhang, createdTime=Mon Feb 08 05:01:01 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394753, encodeId=eb4a1394e534e, content=<a href='/topic/show?id=e31982e0603' target=_blank style='color:#2F92EE;'>#肾脏替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82706, encryptionId=e31982e0603, topicName=肾脏替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406003, encodeId=755b1406003d3, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036323, encodeId=3fde103632393, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Oct 28 21:01:01 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1692871, encodeId=884716928e12c, content=<a href='/topic/show?id=e6d86032ee8' target=_blank style='color:#2F92EE;'>#替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60327, encryptionId=e6d86032ee8, topicName=替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b79d29305168, createdName=wfang555, createdTime=Mon Apr 05 12:01:01 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983692, encodeId=ca51198369295, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Sep 06 20:01:01 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035053, encodeId=915220350537e, content=<a href='/topic/show?id=f02e56353ac' target=_blank style='color:#2F92EE;'>#持续肾脏替代治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56353, encryptionId=f02e56353ac, topicName=持续肾脏替代治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f9e287, createdName=hxzhang, createdTime=Mon Feb 08 05:01:01 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394753, encodeId=eb4a1394e534e, content=<a href='/topic/show?id=e31982e0603' target=_blank style='color:#2F92EE;'>#肾脏替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82706, encryptionId=e31982e0603, topicName=肾脏替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406003, encodeId=755b1406003d3, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036323, encodeId=3fde103632393, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Oct 28 21:01:01 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1692871, encodeId=884716928e12c, content=<a href='/topic/show?id=e6d86032ee8' target=_blank style='color:#2F92EE;'>#替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60327, encryptionId=e6d86032ee8, topicName=替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b79d29305168, createdName=wfang555, createdTime=Mon Apr 05 12:01:01 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983692, encodeId=ca51198369295, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Sep 06 20:01:01 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035053, encodeId=915220350537e, content=<a href='/topic/show?id=f02e56353ac' target=_blank style='color:#2F92EE;'>#持续肾脏替代治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56353, encryptionId=f02e56353ac, topicName=持续肾脏替代治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f9e287, createdName=hxzhang, createdTime=Mon Feb 08 05:01:01 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394753, encodeId=eb4a1394e534e, content=<a href='/topic/show?id=e31982e0603' target=_blank style='color:#2F92EE;'>#肾脏替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82706, encryptionId=e31982e0603, topicName=肾脏替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406003, encodeId=755b1406003d3, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036323, encodeId=3fde103632393, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Oct 28 21:01:01 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-30 chg122
  6. [GetPortalCommentsPageByObjectIdResponse(id=1692871, encodeId=884716928e12c, content=<a href='/topic/show?id=e6d86032ee8' target=_blank style='color:#2F92EE;'>#替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60327, encryptionId=e6d86032ee8, topicName=替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b79d29305168, createdName=wfang555, createdTime=Mon Apr 05 12:01:01 CST 2021, time=2021-04-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1983692, encodeId=ca51198369295, content=<a href='/topic/show?id=628553048e3' target=_blank style='color:#2F92EE;'>#患者死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53048, encryptionId=628553048e3, topicName=患者死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Sep 06 20:01:01 CST 2021, time=2021-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2035053, encodeId=915220350537e, content=<a href='/topic/show?id=f02e56353ac' target=_blank style='color:#2F92EE;'>#持续肾脏替代治#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56353, encryptionId=f02e56353ac, topicName=持续肾脏替代治)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f9e287, createdName=hxzhang, createdTime=Mon Feb 08 05:01:01 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1394753, encodeId=eb4a1394e534e, content=<a href='/topic/show?id=e31982e0603' target=_blank style='color:#2F92EE;'>#肾脏替代治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82706, encryptionId=e31982e0603, topicName=肾脏替代治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7482500171, createdName=ms4468361851264128, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1406003, encodeId=755b1406003d3, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Fri Oct 30 09:01:01 CST 2020, time=2020-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1036323, encodeId=3fde103632393, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Wed Oct 28 21:01:01 CST 2020, time=2020-10-28, status=1, ipAttribution=)]
    2020-10-28 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

Neurology:不同抗凝方法的患者机械血栓切除术的结局比较

该研究强调了DOA相比于VKA的优势。在死亡率、优良结局和再通率方面,DOA似乎为AIS患者的MT治疗提供了有利条件。

Blood:预防性抗凝或可降低镰状细胞病血管阻塞性危象的发病率

血管阻塞性危象(VOC)是镰状细胞病(SCD)发病和住院的主要原因。但目前只有三种治疗方法(羟基脲、l-谷氨酰胺和crizanlizumab)被批准用于治疗SCD。这些药物限制了血管阻塞性危象的持续时间、严重程度和发生频率。凝血激活是SCD的一个标志。对SCD动物模型的研究表明,凝血可导致慢性炎症和与SCD相关的终末器官损伤。但凝血是否直接导致引发VOC的微血管停滞仍是不明确。在本研究中,研究人员

Thorax:硫酸乙酰肝素链造成恶性胸腔积液的抗凝环境

乙酰肝素酶释放的HS链造成MPE的抗凝环境,可防止局部血栓形成并促进肿瘤细胞增殖。抑制乙酰肝素酶为复发性MPE患者提供了一个治疗选择。

JACC:生物瓣膜血栓形成患者远期的抗凝预后研究

在生物瓣膜血栓形成(BPVT)的早期预防和治疗中,抗凝是有效的,但BPVT后的长期疗效尚不清楚。本研究的目的旨在评估接受抗凝治疗的BPVT患者的远期预后。本研究纳入分析了83名因疑似BPVT接受华法林治疗的患者(平均年龄57±18岁,男性占54%),并与166名匹配对照进行对比分析。有62名患者在抗凝治疗后的3个月内心超结果转为正常,21名患者对华法林无反应。经过平均34个月时间的随访,病例组和对

Stroke:抗凝患者的血管内卒中治疗与颅内出血风险

由此可见,机械血栓切除术后服用VKA的患者发生sICH的风险和死亡率增加。在急性期,与DOAC相关的sICH风险较低也很明显。在接受VKA治疗的患者中,建议改善治疗方案。

Circulation:急性冠脉综合征合并房颤患者的更佳抗凝方案!

抗血栓治疗方案的安全性和有效性可能在采用不同治疗方式(经药物治疗、经皮冠状动脉介入治疗[PCI]和选择性PCI)的有房颤表现的ACS患者之间存在差异。研究人员采用2x2的方案设计,对比阿哌沙班和维生素K拮抗剂、阿司匹林和安慰剂用于ACS、进行PCI或采用P2Y12抑制剂治疗的有房颤表现的患者的疗效和安全性。共招募了4614位患者,其中1097位(23.9%)采用药物治疗,1714位(37.3%)采